Mural Oncology Plc盘中异动股价大涨5.42%_老虎社区_美港股上老虎

Mural Oncology Plc盘中异动股价大涨5.42%

市场透视2025-01-18

北京时间2025年01月18日00时40分，Mural Oncology Plc（MURA.us）股票出现异动，股价大幅拉升5.42%。截至发稿，该股报3.89美元/股，成交量3.6351万股，换手率0.21%，振幅4.34%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-31.76百万美元，每股收益-1.87美元，毛利-899000.00美元，市盈率-0.43倍。机构评级方面，在所有...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2504520199?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-01-18 00:40","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2504520199","market":"us","top_or_hot":-1,"title":"Mural Oncology Plc盘中异动 股价大涨5.42%","media":"市场透视","content":"<div>\n<p>北京时间2025年01月18日00时40分，Mural Oncology Plc（MURA.us）股票出现异动，股价大幅拉升5.42%。截至发稿，该股报3.89美元/股，成交量3.6351万股，换手率0.21%，振幅4.34%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-31.76百万美元，每股收益-1.87美元，毛利-899000.00美元，市盈率-0.43倍。机构评级方面，在所有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118004032a225d9b5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mural Oncology Plc盘中异动 股价大涨5.42%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMural Oncology Plc盘中异动 股价大涨5.42%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-18 00:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118004032a225d9b5&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年01月18日00时40分，Mural Oncology Plc（MURA.us）股票出现异动，股价大幅拉升5.42%。截至发稿，该股报3.89美元/股，成交量3.6351万股，换手率0.21%，振幅4.34%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-31.76百万美元，每股收益-1.87美元，毛利-899000.00美元，市盈率-0.43倍。机构评级方面，在所有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118004032a225d9b5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118004032a225d9b5&s=b","article_id":"2504520199","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118004032a225d9b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2504520199","pubTimestamp":1737132031,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年01月18日00时40分，Mural Oncology Plc股票出现异动，股价大幅拉升5.42%。截至发稿，该股报3.89美元/股，成交量3.6351万股，换手率0.21%，振幅4.34%。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.60%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","MURA":"Mural Oncology"},"translate_title":"Mural Oncology Plc shares jumped 5.42% in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MURA":1},"content_text":"北京时间2025年01月18日00时40分，Mural Oncology Plc（MURA.us）股票出现异动，股价大幅拉升5.42%。截至发稿，该股报3.89美元/股，成交量3.6351万股，换手率0.21%，振幅4.34%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-31.76百万美元，每股收益-1.87美元，毛利-899000.00美元，市盈率-0.43倍。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Mural Oncology Plc股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)、Surrozen Inc C/Wts 01/08/2031 (To Pur Com)涨幅较大，Aditxt, Inc.、Silexion Therapeutics Corp、Phio Pharmaceuticals Corp.较为活跃，换手率分别为180.41%、34.62%、29.86%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 (To Pur Com)、Immatics N V C/Wts 01/07/2025 (To Pur Com)、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 (To Pur Ord)，振幅分别为53.37%、51.37%、48.07%。Mural Oncology Plc公司简介：Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。通过利用其在免疫细胞调节和蛋白质工程方面的核心竞争力，该公司开发了一系列新颖的研究性细胞因子疗法，旨在解决各种癌症患者未满足的需求。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}